Glycogen Storage Disease Type II (GSD II) Completed Phase 4 Trials for Alglucosidase alfa (DB01272)

Back to Glycogen Storage Disease Type II (GSD II)

Also known as: Glycogen Storage Disease Type II GSD II / Glycogen Storage Disease Type II (GSD-II)

IndicationStatusPhase
DBCOND0041318 (Glycogen Storage Disease Type II (GSD II))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01410890Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe DiseaseOther
NCT01288027Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase AlfaTreatment
NCT00486889Growth and Development Study of Alglucosidase AlfaTreatment
NCT00483379High Dose or High Dose Frequency Study of Alglucosidase AlfaTreatment
NCT00455195Late-Onset Treatment Study Extension ProtocolTreatment